Researchers found patients who were given a tumor necrosis factor (TNF) inhibitor, a drug used to treat psoriasis, were 50% less likely to have a heart attack compared to patients on other medications.

Doctors said people with psoriasis are at a higher risk for cardiovascular diseases because the condition causes inflammation in the body.